Author

Junko Shoda

Observed name: 正田, 純子

Institution: Saitama Medical University

Observed institution: Saitama Medical University

OpenAlex ID: A5110093039

Effect of Angiotensin Receptor Blockers on Cardiovascular Events in Patients Undergoing Hemodialysis: An Open-Label Randomized Controlled Trial

2008 · Hiromichi Suzuki, Yoshihiko Kanno, et al. · American Journal of Kidney Diseases · 193

Cardio-Ankle Vascular Index to Screen Cardiovascular Diseases in Patients with End-Stage Renal Diseases

2008 · Tsuneo Takenaka, Hitoshi Hoshi, et al. · Journal of Atherosclerosis and Thrombosis · 45

A Fiveyear Comparison of the Renal Protective Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with NonDiabeticNephropathy

2006 · Junko Shoda, Yoshihiko Kanno, et al. · Internal Medicine · 32

Comparison and survival of patients receiving hemodialysis and peritoneal dialysis in a single center.

2007 · Kousuke Uchida, Junko Shoda, et al. · PubMed · 25

Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure.

2006 · Hiroshi Takane, Hidetomo Nakamoto, et al. · PubMed · 21

Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.

2006 · Kazuhiro Kobayashi, Hidetomo Nakamoto, et al. · PubMed · 11

The newly developed calcium antagonist, azelnidipine, increases drain volume in continuous ambulatory peritoneal dialysis patients.

2006 · Hiromichi Suzuki, Tsutomu Inoue, et al. · PubMed · 9

Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis.

2007 · Saiko Okada, Tsutomu Inoue, et al. · PubMed · 7

Risk factors for vascular complications in patients on peritoneal dialysis.

2006 · Hiroshi Arima, Hidetomo Nakamoto, et al. · PubMed · 7

Works count: 10

Citation count: 350

H-index: 7

I10-index: 6